Acadia Pharmaceuticals Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Antisense, Oligonucleotides
Other Names/Subsidiaries
- Receptor Technologies
- CerSci Therapeutics
Latest on Acadia Pharmaceuticals Inc.
Aurobindo and MSN Labs are facing a wait of more than a decade to launch their proposed generic versions of Acadia Pharmaceuticals ’ Nuplazid (pimavanserin tartrate) 34mg capsules after a US feder
Aurobindo and MSN Labs are facing a wait of more than a decade to launch their proposed generic versions of Acadia Pharmaceuticals’ Nuplazid (pimavanserin tartrate) 34mg capsules after a US federal di
The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th
The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th